UNH · 10-Q · 2026Q1 · Full report

Revenue Performance and Mix

UNITEDHEALTH GROUP INC · 2026-05-05 · Importance 42 · Surprise 14

Consolidated revenues were $111,721 million in Q1 2026, up $2,146 million (2%) from $109,575 million in Q1 2025. UnitedHealthcare revenues increased to $86,265 million, up $1,648 million (2%) year-over-year, driven by pricing trends and growth in fee-based commercial offerings. Optum total revenues were essentially flat at $63,749 million versus $63,885 million, with Optum Health down $728 million (3%) to $24,109 million and Optum Rx up to $35,736 million (an increase of $604 million). The revenue change was partially offset by decreases in people served in Medicare Advantage, risk-based commercial offerings and Medicaid, and a decline in patients under value-based arrangements at Optum Health in Q1 2026 versus Q1 2025.

Key facts

• Consolidated revenues were $111,721 million for the three months ended March 31, 2026 compared to $109,575 million for the three months ended March 31, 2025. source
• Premiums revenue was $87,561 million for the three months ended March 31, 2026 compared to $86,534 million for the three months ended March 31, 2025. source
• Optum Rx revenues were $35,736 million for the three months ended March 31, 2026 compared to $35,132 million for the three months ended March 31, 2025. source
• UnitedHealthcare revenues by subsegment included Employer & Individual - Total of $20,118 million and Medicare & Retirement of $42,082 million for the three months ended March 31, 2026. source
• Earnings from operations for UnitedHealthcare were $5,694 million for the three months ended March 31, 2026 compared to $5,226 million for the three months ended March 31, 2025. source
• Optum Rx fulfilled 383 million adjusted scripts in the first quarter of 2026 compared to 408 million adjusted scripts in the first quarter of 2025. source
• The company pledged to rebate 2026 profits on its individual exchange products to customers. source
• By segment, net portfolio divestiture impacts included gains of $528 million at Optum Insight, $8 million at Optum Rx, and a net loss of $306 million at Optum Health. source